NDC 60505-0141-08 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0141
- Requested NDC
- 60505-0141-08
- Package NDCs from labels
- 60505-0141-0, 60505-0141-2, 60505-0141-1, 60505-0141-8, 60505-0141-08
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2026-10-13 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | REMEDYREPACK INC. | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | NuCare Pharmaceuticals,Inc. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Apotex Corp. | Apotex Inc. | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - American Health Packaging | American Health Packaging | 2026-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Coupler LLC | Apotex Inc. | 2026-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | Preferred Pharmaceuticals, Inc. | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Major Pharmaceuticals | Major Pharmaceuticals | 2026-03-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Legacy Pharmaceutical Packaging, LLC | Legacy Pharmaceutical Packaging, LLC | 2026-03-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-20 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg Rx Only | PD-Rx Pharmaceuticals, Inc. | 2026-02-16 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | REMEDYREPACK INC. | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - AvPAK | AvPAK | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Glipizide - QPharma Inc | APOTEX CORP. | Northwind Health Company, LLC | QPharma Inc | APOTEX CORP. | Northwind Health Company, LLC | 2025-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | NuCare Pharmaceuticals,Inc. | 2025-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0141-0 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 60505-0141-1 | Glipizide | 1000 in 1 BOTTLE | TABLET | 1000 | 13 | |
| 60505-0141-2 | Glipizide | 500 in 1 BOTTLE | TABLET | 500 | 13 | |
| 60505-0141-8 | Glipizide | 18000 in 1 BOTTLE | TABLET | 18000 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0141 | GLIPIZIDE TABLET [APOTEX CORP.] | 12 | Current NDC, Legacy NDC, 4 package rows | 20240927_dcf426b8-bcdc-8214-a1b6-6388bd3399a0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0141-0 | EA - Each | 60505-0141 | 060fe002-7e4b-48fa-b8ff-db2d3828c7f4 | 1 | 2012-07-24 |
| 60505-0141-1 | EA - Each | 60505-0141 | e7c50d52-216d-49a4-af7f-5c321f139ee5 | 1 | 2012-07-24 |
| 60505-0141-2 | EA - Each | 60505-0141 | f4681913-5f1e-4f36-a5c9-bb72a51d1b76 | 1 | 2012-07-24 |
| 60505-0141-8 | EA - Each | 60505-0141 | 1dbe3016-8158-4460-bb2b-dd466eed8d63 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide and metformin hcl | GLIPIZIDE AND METFORMIN HCL | Chartwell RX, LLC | ac018f64-fd9d-4b3c-b0ac-ca305b8df635 | 2026-11-05 | Boxed warning, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 726fd41e-7831-4f94-8b28-d139105aad68 | 2026-11-04 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | a59e2aaf-692c-4696-817b-3fed7a9dc52c | 2026-11-04 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a38cfe61-4aa5-498c-bca5-03a8213303bb | 2026-10-14 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 16fb8bc7-1db1-477e-a201-b3b678b8a84c | 2026-10-13 | Warnings, Adverse reactions | ANDA075795 50090-0502-3 50090-0502-2 50090-0502-0 50090-0502-4 50090-0502-1 50090-0502 310490 ce91d164-c1bd-4d90-8805-b2bd3047f661 16fb8bc7-1db1-477e-a201-b3b678b8a84c X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | ccfa5a38-3f90-48f4-b226-51e91497c06f | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | 2110a7ca-3c1f-4db4-9211-65546b74533c | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 41d4e09b-b90c-4243-acd8-f2e06ebf4089 | 2026-10-09 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 861609da-6f69-43cf-a6a3-9f45a1d9eb23 | 2026-10-02 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | c38c3c72-0ef2-4c06-8c67-a3f428ad172b | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals, Inc. | 5ce323e4-ea8c-22b5-e063-6294a90a15bf | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 04e18105-0bd2-4353-b7d2-a73749de32b8 | 2026-09-29 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | d9b6464f-6fe6-446e-8150-d0c15c46fee8 | 2026-09-28 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 1b2e5656-9da9-4fab-bf01-ed75896b836a | 2026-09-23 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 3f2599c6-9e33-487e-9379-6477bb121461 | 2026-09-22 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 212897cb-7de7-4711-aaf4-44234f950e9f | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 70518-0552-4 70518-0552-5 70518-0552-1 70518-0552-3 70518-0552-2 70518-0552-0 70518-0552 310490 5c17772f-378d-1fec-e063-6394a90a01fd 212897cb-7de7-4711-aaf4-44234f950e9f X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 376ce3cf-4e1b-4b5f-b3e7-cc9fc4a5aeb4 | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Oxford Pharmaceuticals, LLC | 87cd4930-ba68-4acf-bf74-619c477b557d | 2026-09-17 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals,Inc. | 6282c653-9e9c-6810-e053-2991aa0a4a8e | 2026-09-14 | Warnings, Adverse reactions | ANDA075795 68071-4223-9 68071-4223-6 68071-4223-8 68071-4223-3 68071-4223 310490 5b75f1f3-0bc0-31ab-e063-6394a90a1f5d 6282c653-9e9c-6810-e053-2991aa0a4a8e X7WDT95N5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.